We are live on ! Find out more
GS

GTS Securities Portfolio holdings

AUM $2.83B
1-Year Est. Return 21.76%
This Fund
S&P 500
This Quarter Est. Return
+2.34%
1 Year Est. Return
+21.76%
3 Year Est. Return
+68.93%
5 Year Est. Return
10 Year Est. Return
AUM
$46.9B
AUM Growth
-$7.57B
Cap. Flow
-$10.6B
Cap. Flow %
-22.49%
Top 10 Hldgs %
39.98%
Holding
4,462
New
694
Increased
1,508
Reduced
1,649
Closed
587

Sector Composition

Rank Sector Weight
1 Technology 2.24%
2 Consumer Discretionary 1.07%
3 Communication Services 0.69%
4 Financials 0.59%
5 Healthcare 0.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HA
4426
PUT
DELISTED
Hawaiian Holdings, Inc.
HA
-50,300
Closed -$670K
TUP
4427
DELISTED
Tupperware Brands Corporation
TUP
-16,336
Closed -$23.1K
BIG
4428
DELISTED
Big Lots, Inc.
BIG
-38,428
Closed -$124K
SPWR
4429
DELISTED
SunPower Corporation Common Stock
SPWR
-39,541
Closed -$108K
TWOU
4430
CALL
DELISTED
2U Inc
TWOU
-397
Closed -$4.64K
MOR
4431
PUT
DELISTED
MorphoSys AG American Depositary Shares
MOR
-38,500
Closed -$698K
SLCA
4432
PUT
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
-29,500
Closed -$366K
ETRN
4433
PUT
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
-13,600
Closed -$170K
HDAW
4434
DELISTED
Xtrackers MSCI All World ex US High Dividend Yield Equity ETF
HDAW
-9,786
Closed -$244K
WIRE
4435
DELISTED
Encore Wire Corp
WIRE
-980
Closed -$276K
WIRE
4436
PUT
DELISTED
Encore Wire Corp
WIRE
-1,500
Closed -$394K
FUSN
4437
CALL
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
-11,400
Closed -$243K
FUSN
4438
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
-29,095
Closed -$620K
FUSN
4439
PUT
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
-31,400
Closed -$669K
SWAV
4440
CALL
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
-2,700
Closed -$879K
SWAV
4441
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
-2,085
Closed -$679K
SWAV
4442
PUT
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
-10,700
Closed -$3.48M
PUCKW
4443
DELISTED
Goal Acquisitions Corp. Warrant
PUCKW
-20,206
Closed -$121
ALPN
4444
DELISTED
Alpine Immune Sciences Inc
ALPN
-8,499
Closed -$337K
ALPN
4445
PUT
DELISTED
Alpine Immune Sciences Inc
ALPN
-7,900
Closed -$313K
OSI.WS
4446
DELISTED
Osiris Acquisition Corp. Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
OSI.WS
-10,321
Closed -$310
MRNS
4447
PUT
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
-17,000
Closed -$154K
CLVRW
4448
DELISTED
Clever Leaves Holdings Inc. Warrant
CLVRW
-11,279
Closed -$440
USVT
4449
DELISTED
US Value ETF
USVT
-7,009
Closed -$223K
PXD
4450
CALL
DELISTED
Pioneer Natural Resource Co.
PXD
-4,900
Closed -$1.29M

Similar funds

GTS Securities's Q2 2024 Portfolio in Review

As of Q2 2024, GTS Securities held 4,462 positions worth $46.9B, down 14% from $54.5B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

GTS Securities withdrew a net $10.6B in Q2 2024, closing 587 positions and reducing 1,649 holdings. Its most notable exit was Trip.com Group, an estimated $26.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 2.2% of assets, up from 1.5% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, GTS Securities opened a new position in State Street Technology Select Sector SPDR ETF worth $64.1M.

  • GTS Securities's largest Q2 2024 buy was State Street Technology Select Sector SPDR ETF: 566,626 shares worth $64.1M.
  • GTS Securities added most to Invesco QQQ Trust in Q2 2024, an estimated $251M increase.
  • GTS Securities's biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $109M.
  • GTS Securities fully exited Trip.com Group in Q2 2024, selling an estimated $26.6M.
  • GTS Securities's ten largest holdings make up 40% of its $46.9B portfolio in Q2 2024.
  • GTS Securities opened 694 new positions and closed 587 in Q2 2024.
  • GTS Securities's portfolio value fell 14% quarter-over-quarter to $46.9B.

Based on GTS Securities's 13F filing for Q2 2024, filed 14 Aug 2024.